Prevalence of platinum-induced ototoxicity among patients suffering from hematological malignancies – a systematic review
Platinum-based compounds used for treating hematologic malignancies can lead to various side effects. One such side effect is ototoxicity, which is characterized by permanent bilateral sensorineural hearing loss or tinnitus. Initially, it mainly affects high frequencies, but as the condition progres...
Saved in:
Main Authors: | Aleksandra Janowiak-Majeranowska, Gazala Abdulaziz-Opiela, Jakub Osowski, Bogusław Mikaszewski |
---|---|
Format: | Article |
Language: | English |
Published: |
Termedia Publishing House
2024-07-01
|
Series: | Contemporary Oncology |
Subjects: | |
Online Access: | https://www.termedia.pl/Prevalence-of-platinum-induced-ototoxicity-among-patients-suffering-from-hematological-malignancies-a-systematic-review,3,54519,1,1.html |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Insight into the current practice of ototoxicity monitoring during cisplatin therapy
by: N. M. Santucci, et al.
Published: (2021-03-01) -
A Prospective Observational Study to Establish a Correlation Between Tinnitus and Hearing Loss
by: Anshu Chopra, et al.
Published: (2024-11-01) -
Can floseal™ be applied safely during otologic surgery? Assessment of ototoxicity in a chinchilla animal model
by: Carol Nhan, et al.
Published: (2017-03-01) -
Bioinformatic characterization of STING expression in hematological malignancies reveals association with prognosis and anti-tumor immunity
by: Xiang-mei Wen, et al.
Published: (2025-02-01) -
Knowledge on the Use of Biosimilars in Hematological Malignancies Amongst Health Care Workers at a Tertiary Hospital in Northeast Nigeria
by: Rufai A. Dachi, et al.
Published: (2024-07-01)